The inexorable increase of biologic exposure in paediatric inflammatory bowel disease: a Scottish, population‐based, longitudinal study

BACKGROUND: The use of biologics in paediatric‐onset inflammatory bowel disease (PIBD) is rapidly changing. AIMS: To identify the incidence and prevalence of biologic use within Scottish PIBD services, and to describe patient demographics and outcomes for those patients who required escalation of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgess, Christopher J., Jackson, Rebecca, Chalmers, Iain, Russell, Richard K., Hansen, Richard, Scott, Gregor, Henderson, Paul, Wilson, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Use of Biologics in Paediatric IBD
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828169/
https://www.ncbi.nlm.nih.gov/pubmed/36196524
http://dx.doi.org/10.1111/apt.17217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828169/
https://www.ncbi.nlm.nih.gov/pubmed/36196524
http://dx.doi.org/10.1111/apt.17217

Ejemplares similares